James increased its price target on shares of NOV Inc. (NYSE:NOV) to $19.00, up from the previous target of $18.00, while keeping an Outperform rating on the stock. Currently trading at $16.43, NOV ...

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. BTIG 12th Annual MedTech, ...

James made an adjustment to the price target for AMD stock, lowering it from $180 to $150, but retained an Outperform rating. Currently trading at $119.50, AMD sits near its 52-week low of $112.80, ...

The presentation being reviewed today is available on Raymond James' Investor Relations website. Following the prepared remarks, the operator will open the line for questions. Calling your ...

Raymond James said this when discussing the Analysts ... Equinix enables organizations to access all the right places, partners, and possibilities to scale with agility, speed the launch ...

See LPL Financial’s investor presentation for its earnings release. Raymond James also ended 2024 with growth, posting record quarterly net revenues of $3.54 billion, up 17% over the prior year ...

In a report released today, Daniel Tamayo from Raymond James maintained a Buy rating on Merchants Bancorp (MBIN – Research Report), with a ...